I get more and more the opinion that it´s mainly a
I get more and more the opinion that it´s mainly a psychological problem, especially for us who have invested at a low pps-stage and saw this just growing strongly and fast ... a good example are 900K shares I hold in my Austrian account since 01/2013 ... average buying-price: exactly 0.005 ... imagine this incredible gain of those shares within a year (until Dec. 2013): 35-fold!!!!!!! And despite this ugly development afterwards they are still a 12-bagger today.
If you have such an experience (accompanied by an awesome company-quality in many regards like reliability, honesty etc.) you naturally become spoiled, and that BIGTIME! Mainly as one who went through several (expensive) disappointments before.
So 2013 for us was a really occuring life-example kinda "too good to be true" ... and with that experience any comparison resp. contrast with 2014 has to look terrible (probably not for one who got in let´s say in spring or later) ...
And this negative development not only was pps-wise but also re. the 180°-changed behavior of the company, at all and to us shareholders ...
The recent news and pps-gains unfortunately are history, and 2014 as synonym for a disgusting NTEK-phase looks will continue ... very tough to stay optimistic right now ... looks we have to wait several further months, however, this time with downgraded hopes, less excitement and conviction, however much more sense for reality, far away from dreaming ... 2013 was a dream-year ... a dream got reality ... this current year we have to accept the other side of reality, unfortunately ...
Could be today some investor got out ... I should have done this last December, at least with half of my overall several M shares, at a 3-multiple of today´s pps.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Growth Forecast for the IVD Reagents Market The global In Vitro Diagnostic (IVD) reagents market is on an impressive trajectory to reach nearly USD 55.3 billion by 2029. The demand for IVD reagents has surged, driven by numerous factors such as a rising prevalence of chronic and infectious diseases, alongside a growing emphasis on preventive healthcare. In 2022, the IVD...
Continue Reading
Exciting Growth at Cayuga Centers With New Board Members Cayuga Centers is thrilled to announce the welcoming of nine new members to its Board of Trustees. This addition of distinguished professionals promises to enhance the agency's leadership and the resources it employs to support children, youth, and families across the nation. Each of these new board members brings a...
Continue Reading
Elements Massage Celebrates National Skin Care Awareness Month As National Skin Care Awareness Month comes to an end, Elements Massage, the nation's leading massage therapy concept, is highlighting skincare and wellness. Innovative Skincare Services Elements Massage has introduced enhanced skincare services in collaboration with Sanitas Skincare. This partnership marks...
Continue Reading
Understanding Danaher's Stock Growth Danaher Corporation (NYSE: DHR) has consistently demonstrated robust performance in the stock market. With an average annual return of 13.82%, it has outpaced the market by 1.08% over the past decade. Currently, Danaher boasts a commendable market capitalization of $163.05 billion. Investment Insight: What If You Invested $100? Let’s...
Continue Reading
Matthew A. Cartwright Rejoins Munley Law as Of Counsel The six-term Congressman brings decades of legal expertise and legislative accomplishments back to the Pennsylvania personal injury law firm. MUNLEY Law is excited to announce the return of former U.S. Representative Matthew A. Cartwright as Of Counsel. Following a commendable 12 years in Congress, Cartwright brings a...
Continue Reading